Quantum Biopharma (QNTM) Expected to Announce Earnings on Thursday

Quantum Biopharma (NASDAQ:QNTMGet Free Report) is projected to issue its quarterly earnings data before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.80) per share for the quarter.

Quantum Biopharma Price Performance

QNTM stock opened at $5.86 on Wednesday. The company’s 50 day simple moving average is $5.92 and its 200-day simple moving average is $4.97. Quantum Biopharma has a 52-week low of $2.70 and a 52-week high of $18.00. The firm has a market capitalization of $11.25 million, a P/E ratio of -0.38 and a beta of 0.37.

About Quantum Biopharma

(Get Free Report)

Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company’s three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS.

Featured Articles

Earnings History for Quantum Biopharma (NASDAQ:QNTM)

Receive News & Ratings for Quantum Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.